Company Filing History:
13 out of 3,539 
5 out of 559 
3 out of 2,660 
Years Active: 2010-2024
Title: Innovations in Cancer Treatment by Inventor Yang Feng
Introduction
Yang Feng is a prominent inventor based in Frederick, MD (US), known for his significant contributions to cancer treatment through innovative methods and compositions. With a total of 14 patents to his name, he has made remarkable strides in the field of immunotherapy.
Latest Patents
Among his latest patents, Yang Feng has developed methods of treatments using antigen-binding proteins targeting CD56. This subject matter provides for methods and compositions for treating cancer, particularly multiple myeloma. It involves anti-CD56 antibodies and chimeric antigen receptors (CARs) that specifically target human CD56, enhancing immune-activating properties and anti-tumor activity. Another notable patent focuses on reducing mesothelin-expressing tumor burden by administering T cells comprising mesothelin-targeted chimeric antigen receptors. This innovation aims to enhance the immune response toward cancers and pathogens, utilizing CARs that specifically target human mesothelin.
Career Highlights
Yang Feng has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Memorial Sloan Kettering Cancer Center. His work in these institutions has significantly contributed to advancements in cancer research and treatment.
Collaborations
Yang Feng has collaborated with notable professionals in the field, including Dimiter Stanchev Dimitrov and Michel Sadelain. These collaborations have further enriched his research and innovations in cancer therapies.
Conclusion
Yang Feng's innovative work in cancer treatment through his patents and collaborations highlights his dedication to advancing medical science. His contributions are paving the way for more effective therapies in the fight against cancer.